Open

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

National Institutes of Health·Government

AI Summary

The National Institutes of Health is seeking early-stage innovative technology development for basic and clinical cancer research. The opportunity is open to eligible applicants and the deadline for submission is November 10, 2026.

Deadline
Tuesday, November 10, 2026
Value
Not specified
Location
US
Contract
Not specified
Duration
Not specified
Remote
Not specified
Source
grants-gov
Posted
June 3, 2026
Team Size
Not specified

Full Description

Title: Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Agency: National Institutes of Health Agency Code: HHS-NIH11 Status: posted Document Type: synopsis Open Date: 06/03/2026 Close Date: 11/10/2026 CFDA Numbers: 93.394 Opportunity Number: RFA-CA-27-001 Opportunity ID: 360536
View Original RFP